LRRK2 and inflammatory bowel disease: Further meta-analyses of GWAS data including both CD and UC patients, identified rs11564258 at the same loci, confirming the significant association with candidate genes LRRK2 and MUC19 and the risk of IBD (Franke et al., 2010).